Backabrdn Life Sciences Investors Overview

abrdn Life Sciences Investors Selling, General & Admin

See how HQL's SG&A expenses trends over time vs similar companies.

Get informed when a big investor buys or sells

+ Follow

Quarterly SG&A Expenses

N/A

As of Mar 31, 2026

Annual SG&A Expenses (TTM)

$3.92M
136656.24% YoY

Trailing 12 months ending Mar 31, 2026

Average SG&A Expenses (Comparison Companies)

Selling, General & Admin History

Selling, General & Admin Comparison

Annual Selling, General & Admin Growth Rate (%)

Annual Selling, General & Admin Growth (Absolute)

abrdn Life Sciences Investors (HQL) FAQ

Stockcircle tracks selling, general & admin for abrdn Life Sciences Investors (HQL), including historical charts and peer comparisons when data is available. Check back as new filings are published, or open the stock overview for a broader fundamental snapshot.

This Selling, General & Admin page is built for abrdn Life Sciences Investors's historical SG&A expenses trend and peer context. When enough reporting periods are on file, the charts below visualize how the metric has moved over time.

Use SG&A expenses as one input alongside growth, profitability, valuation, and ownership activity. Stockcircle links related metric pages and the main HQL overview so you can move from this figure to the surrounding analysis quickly.